Research & Development
Browse Posts in Research & Development
NeuroVive Discontinues – CicloMulsion
NeuroVive Pharmaceutical AB, the mitochondrial medicine company, today announced results from the exploratory clinical phase II study CiPRICS
View ArticleRheumatoid Arthritis Forecast 2016-2026
Research and Markets has announced the addition of the Rheumatoid Arthritis Forecast in 17 Major Markets 2016-2026 report to their…
View ArticleAnesthesia Breathing Circuits – Growth of 2.36%
Research and Markets has announced the addition of the Global Anesthesia Breathing Circuits Market 2016-2020 report to their offering. Anesthesia…
View ArticleMedical Assistants Nationwide
Thousands of medical assistants across the country will be celebrated between October 17 and 21 in observance of Medical Assistants…
View ArticleThe Japanese Cancer Association
Debiopharm Group, a Swiss-based global biopharmaceutical company, will be presenting the 'JCA-Mauvernay Award' on October 8 to Doctors Hidewaki Nakagawa…
View ArticleCanon BioMedical Products Launched
Canon BioMedical is pleased to announce the launch of Novallele genotyping products in the United Kingdom and Ireland for sale…
View ArticleMylan Launches Generic Fortamet’ Tablets
Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Metformin Hydrochloride Extended-release Tablets USP, 500 mg and 1000…
View ArticleExplore Other Categories